Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer
Authors:
- R. DanesiRDR. Danesi
- F. De BraudFBF. De Braud
- T. De PasTPT. De Pas
- G. CuriglianoGCG. Curigliano
- E. GiovannettiE. Giovannetti
- M. Del TaccaMTM. Del Tacca
Open Access
- 1 November 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 12 (11) , 1553-1559
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Schedule dependent toxicity and efficacy of combined gemcitabine/paclitaxel treatment in mouse adenocarcinomaJournal of Cancer Research and Clinical Oncology, 2000
- Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancerAnnals of Oncology, 2000
- The pharmacokinetics of a 1-h paclitaxel infusionCancer Chemotherapy and Pharmacology, 2000
- Adjuvant and Neoadjuvant Chemotherapy for Non-Small Cell Lung CancerChest, 2000
- The TaxoidsDrugs, 1998
- GemcitabineDrugs, 1997
- Antitumor activity of prolonged as compared with bolus administration of 2′,2′-difluorodeoxycytidine in vivo against murine colon tumorsCancer Chemotherapy and Pharmacology, 1996
- Metabolism of taxol by human and rat liver in vitro: A screen for drug interactions and interspecies differencesCancer Chemotherapy and Pharmacology, 1995
- Antimicrotubule agents induce polyploidization of human leukaemic cell lines with megakaryocytic featuresEuropean Journal of Clinical Investigation, 1993
- MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoringComputers in Biology and Medicine, 1992